FDA Inspection 979218 — Vitalant

Vitalant — FEI 2070111

The FDA completed an inspection of Vitalant on June 27, 2016 in Santa Barbara, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 27, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Santa Barbara, CA (United States)